protein

CDKN1B Protein, Human (His)

HY-P70037

10 μg;50 μg

165;496 USD

CDKN1B Protein, Human (His)

proteins

E. coli

10 μg;50 μg

165;496 USD

The CDKN1B protein is a key cell cycle regulator that inhibits CDK2 when bound to cyclin A, thereby inhibiting G1 phase progression. It exhibits significant inhibitory effects on cyclin E- and cyclin A-CDK2 complexes. CDKN1B Protein, Human (His) is the recombinant human-derived CDKN1B protein, expressed by E. coli , with N-6*His labeled tag. The total length of CDKN1B Protein, Human (His) is 198 a.a., with molecular weight of ~30.0 kDa.

Human

The CDKN1B protein serves as a pivotal regulator in cell cycle progression, exerting its influence through multifaceted interactions and activities. Acting as a potent inhibitor, CDKN1B restrains the kinase activity of CDK2 when bound to cyclin A, while exhibiting lesser inhibitory effects on CDK2 associated with SPDYA. This protein is intricately involved in G1 arrest and displays a pronounced inhibitory impact on cyclin E- and cyclin A-CDK2 complexes. Notably, it forms complexes with cyclin type D-CDK4, playing a crucial role in their assembly, stability, and modulation of CCND1-CDK4 complex activation. The phosphorylation state and stoichiometry of CDKN1B determine whether it functions as an inhibitor or activator of cyclin type D-CDK4 complexes. Additionally, CDKN1B engages in diverse interactions, including those with proteins such as CCNE1, COPS5, NUP50, 14-3-3, AKT1, LYN, CDK2, SPDYA, cyclin D, CDK4, GRB2, PIM1, SKP1, SKP2, CKS1B, UHMK1, and CDK1, highlighting its versatility in modulating cell cycle dynamics. Notably, its dephosphorylation on Thr-187 by PPM1H contributes to CDKN1B stability.

rHuCyclin-dependent kinase inhibitor 1B/CDKN1B, His; Cyclin-Dependent Kinase Inhibitor 1B; Cyclin-Dependent Kinase Inhibitor p27; p27Kip1; CDKN1B; KIP1

Greater than 95% as determined by reducing SDS-PAGE

Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.

Room temperature in continental US; may vary elsewhere.